Kidney Transplantation Clinical Trials

A listing of Kidney Transplantation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 277 clinical trials
Featured trial
BIVV020 in Prevention and Treatment of Antibody-mediated Rejection (AMR)  

transplant participants To characterize the pharmacokinetic (PK) profile of BIVV020 in kidney transplant participants To evaluate the immunogenicity of BIVV020

kidney transplant
ivig
tacrolimus
corticosteroids
  • 16 views
  • 25 Jan, 2023
  • 20 locations
Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

The purpose of this research is to see if a dose of the Janssen Ad26.CoV2.S vaccine effects the immune protection in individuals who have had a kidney transplant and two or three doses of mRNA

  • 0 views
  • 04 Oct, 2022
  • 3 locations
A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for the Treatment of Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients (IMAGINE)

This trial investigates the efficacy and safety of clazakizumab [an anti-interleukin (IL)-6 monoclonal antibody (mAb)] for the treatment of CABMR in recipients of a kidney transplant.

  • 142 views
  • 25 Oct, 2022
  • 69 locations
A Controlled, Open-label PA Efficacy and Safety Study in Imlifidase Desensitised Kidney Tx Patients With Positive XM Against a Deceased Donor Prior to Imlifidase Treatment, Including Non-comparative Registry and Concurrent Reference Cohorts (PAES)

(XM) against a deceased donor prior to desensitized with imlifidase and subsequent kidney transplantation. Two non-comparative reference cohorts are included to assess the impact of differences in

  • 0 views
  • 16 Oct, 2022
  • 6 locations
BIVV020 in Prevention and Treatment of Antibody-mediated Rejection (AMR)

transplant participants To characterize the pharmacokinetic (PK) profile of BIVV020 in kidney transplant participants To evaluate the immunogenicity of BIVV020

kidney transplant
corticosteroids
tacrolimus
ivig
  • 0 views
  • 07 Oct, 2022
  • 16 locations
Establishment of a Personalized Pharmaceutical Plan in Renal or Hepatic Transplant Patients (GREPH)

The main objective of the study is to evaluate the impact of the Personalized Pharmaceutical Plan on the therapeutic adherence to immunosuppressive treatments one year after liver or kidney

  • 0 views
  • 10 Mar, 2022
  • 4 locations
A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV (CKD)

The aim of this Phase 2 study is to evaluate the safety and efficacy of the live biotherapeutic product, KT-301 (formerly US-APR2020), in the management of patients with CKD Stage IV.

  • 11 views
  • 22 Oct, 2022
  • 5 locations
Curcumin in Kidney Transplant Recipients

The primary goal of this study is to investigate if curcumin is beneficial for kidney transplant recipients, a population with extensive baseline vascular dysfunction and cognitive impairment

  • 7 views
  • 13 Mar, 2022
  • 1 location
CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients

This is a Phase II/III, Single-center, Prospective, Open-label, Single Arm Study of 30 Simultaneous Kidney Pancreas recipients who received a transplant at least 3 months, but no more than 5 years prior, with a history of tremors following transplantation.

  • 1 views
  • 21 Apr, 2022
  • 1 location
Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection

The purpose of this study is to determine the feasibility and efficacy of detecting kidney transplant rejection using contrast enhance ultrasonography with the contrast agent Sonazoid.

kidney transplant
  • 16 views
  • 04 Mar, 2022